Filter
427
Text search:
immunocompromised
Featured
Recommendations
54
New Publications
73
Language
Document type
No document type
169
Guidelines
144
Studies & Reports
43
Fact sheets
23
Manuals
22
Strategic & Response Plan
11
Training Material
7
Situation Updates
3
Infographics
3
Brochures
1
Resource Platforms
1
Countries / Regions
India
26
Western and Central Europe
16
Latin America and the Carribbean
13
South Africa
11
Global
9
Africa
8
Kenya
7
Philippines
5
Syria
5
Middle East and North Africa
5
Nigeria
4
Mozambique
4
Ukraine
4
West and Central Africa
4
Eastern Europe and Central Asia
4
Germany
3
Tanzania
3
Rwanda
3
Malawi
3
Brazil
3
East and Southern Africa
3
South–East Asia Region
3
Venezuela
3
Eastern Europe
3
Russia
3
Congo, Democratic Republic of
2
Mali
2
USA
2
Ethiopia
2
Niger
2
Nepal
2
Zambia
2
Indonesia
2
Argentina
2
Myanmar / Burma
2
Chile
2
Yemen
2
Burkina Faso
1
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Cameroon
1
Ghana
1
Uganda
1
Zimbabwe
1
Haiti
1
Somalia
1
Pakistan
1
South Sudan
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Egypt
1
Chad
1
Mauritania
1
Bangladesh
1
Singapore
1
Sudan
1
Benin
1
Dominican Republic
1
Peru
1
Eswatini/ Swaziland
1
North Macedonia
1
Cuba
1
Colombia
1
Honduras
1
Ecuador
1
El Salvador
1
Bolivia
1
Libya
1
Guatemala
1
Madagascar
1
Lesotho
1
Mexico
1
Nicaragua
1
Western Pacific Region
1
Asia
1
Albania
1
Congo-Brazzaville
1
Qatar
1
Kazakhstan
1
Georgia
1
North America
1
France
1
Tunisia
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
115
Clinical Guidelines
77
Public Health
12
Women & Child Health
12
Key Resources
10
Pharmacy & Technologies
10
Capacity Building
1
Toolboxes
COVID-19
115
TB
59
HIV
31
Rapid Response
23
AMR
22
NTDs
15
Refugee
10
Planetary Health
10
Ebola
7
Cholera
6
Polio
5
Conflict
5
Caregiver
5
Pharmacy
5
Zika
4
Disability
3
Natural Hazards
3
Mental Health
2
Global Health Education
2
Health Financing Toolbox
1
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been
...
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no
...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian
...
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
Nature | Vol 600 | 2 December 2021 |
The strategy recommends that AU Member States should enhance, where feasible, existing COVID-19 surveillance to include:
Community-based surveillance to detect symptomatic cases early for treatment and to avert viral transmission;
Sentinel surveillance in high-risk populations to detect
...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
orientations provisoires, première publication le 25 janvier 2021, mise à jour le 15 juin 2021, mise à jour le 19 novembre 2021
Climate change and health vulnerability and adaptation assessment
In 2013 the World Health Organization (WHO) published the report Protecting health from climate change:
vulnerability and adaptation assessment. The aim was to provide basic and flexible guidance on conducting national or subnati
...
Updated Treatment Guidelines
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij
...
Cancer centres are a major resource in ensuring a comprehensive approach to cancer treatment and its planning. As part of a new roadmap developed by WHO and IAEA to help countries design national cancer control programmes, this publication proposes a framework to develop a cancer centre and/or to st
...
